T3DB: the toxic exposome database
暂无分享,去创建一个
David S. Wishart | Craig Knox | Yannick Djoumbou | Yifeng Liu | Allison Pon | Michael Wilson | Yongjie Liang | Anchi Guo | David Arndt | Jason R. Grant | Stephen M. Rappaport | Tanvir Sajed | Seyed Ali Goldansaz | D. Wishart | Craig Knox | Anchi Guo | Yongjie Liang | Allison Pon | Yannick Djoumbou | Yifeng Liu | S. Rappaport | J. Grant | S. A. Goldansaz | Tanvir Sajed | David Arndt | Michael Wilson | Craig K. Knox
[1] David M. Reif,et al. Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays , 2013, Chemical research in toxicology.
[2] Thomas C. Wiegers,et al. The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..
[3] Miron Livny,et al. BioMagResBank , 2007, Nucleic Acids Res..
[4] Christoph Steinbeck,et al. The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013 , 2012, Nucleic Acids Res..
[5] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[6] David S. Wishart,et al. SMPDB: The Small Molecule Pathway Database , 2009, Nucleic Acids Res..
[7] David S. Wishart,et al. T3DB: a comprehensively annotated database of common toxins and their targets , 2009, Nucleic Acids Res..
[8] Kamyar Kalantar-Zadeh,et al. Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease , 2013, American Journal of Nephrology.
[9] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[10] Mick Ballesteros,et al. 161 An evaluation of CDC’s web-based injury statistics query and reporting system (WISQARS) , 2016 .
[11] Xin Wen,et al. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..
[12] Li Hui Chen,et al. Drug poisoning deaths in the United States, 1980-2008. , 2011, NCHS data brief.
[13] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[14] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[15] Susumu Goto,et al. KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..
[16] Henrik Druid,et al. Incidence of fatal adverse drug reactions: a population based study. , 2008, British journal of clinical pharmacology.
[17] Alan D. Lopez,et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[18] Tomoyoshi Soga,et al. Oncometabolites: linking altered metabolism with cancer. , 2013, The Journal of clinical investigation.
[19] Paolo Vineis,et al. The Blood Exposome and Its Role in Discovering Causes of Disease , 2014, Environmental health perspectives.
[20] A. Grizzle,et al. Drug-related morbidity and mortality: updating the cost-of-illness model. , 2001, Journal of the American Pharmaceutical Association.
[21] Z. Massy,et al. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. , 2013, Journal of the American Society of Nephrology : JASN.